Dentist jailed for seeing Perth clients during mandatory coronavirus self-quarantine

A Perth dentist has been sentenced to two months’ immediate jail for breaching COVID-19 quarantine requirements and treating 41 patients despite knowing the health risk posed by the virus.

During sentencing in the Joondalup Magistrates Court, Magistrate Matthew Walton told Natalia Nairn her offending constituted a “contemptible disregard” for the rules.

He said she could have been responsible for spreading the virus through the community.

“The offender did pose a significant risk to the health and safety of West Australians,” Magistrate Walton said.

Nairn flew back to Perth from Canberra on June 16 via Sydney and was supposed to quarantine at home for two weeks.

But the court heard on seven or eight occasions, she left her home to work at a dental clinic and treated 41 patients.

She even went to the dental clinic again after police tried to contact her at her home over the breach.

She was charged with eight offences of failing to comply with a direction under the Emergency Management Act.

Nairn pleaded guilty on October 21.

Magistrate dismisses ‘feeling fine’ defence

Magistrate Walton said Nairn’s view she did not pose a risk because she was “feeling fine” was “patently ridiculous” and “staggeringly naive or at the very least irrelevant”.

He said she knew the risk and in fact wore PPE while treating patients.

“She took those measures to fundamentally protect herself,” he said.

Magistrate Walton described the crimes as deliberate and at the “upper range of seriousness”.

He said she risked potentially freshly introducing COVID-19 into the state, through 41 patients who could have then spread it through their own networks and contacts.

He took into consideration her remorse, early guilty plea and the fact she may be registered as a dentist.

But he said the offending warranted a jail term.

Nairn was sentenced to two months in prison, as well as another five months suspended for a period of eight months.

Source Article

Read More

Inovalon Clients Outperform Market for CMS Star Ratings for the Seventh Year in a Row

The Inovalon ONE® Platform Supports Meaningful Quality Outcomes Improvements and Value Delivery

BOWIE, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that clients utilizing Inovalon’s quality improvement solution suite outperformed the entire Medicare Advantage market for the seventh year in a row, realizing a positive increase of nearly 4% on a year-over-year basis in their Centers for Medicare & Medicaid Services (CMS) 2021 Star Ratings.

Inovalon’s clinical quality data aggregation, advanced analytics, integrated outreach, and data visualization toolsets provide health plans with targeted patient-level insights to improve quality of care and member health outcomes. Able to integrate, aggregate, and analyze the growing volume of healthcare datasets at high speed to support improvements in clinical quality outcomes measures, the Inovalon ONE® Platform delivers the nation’s most widely used healthcare quality data analysis and improvement platform, with more than 76% of U.S. reported lives running through the Inovalon Platform in 2020.

These results reflect data released by CMS on October 9, 2020, pertaining to all Medicare Advantage and Prescription Drug Plans, which revealed that on a year-over-year basis, Star Rating scores decreased by 2.17% for the average Medicare Advantage health plan on an enrollment-weighted basis. These results also reflect adjustments CMS made to minimize the impact of the ongoing COVID-19 pandemic, allowing plans to use the higher of their 2020 or 2021 CMS Star Ratings for approximately 50% of the measures. Despite the overall market decreasing by 2.17%, clients leveraging Inovalon’s quality improvement suite realized an average increase of 3.72% in their 2021 Star Ratings. The achievement of higher Star Ratings reflects the great work of Inovalon’s health plan clients and the ability of the Inovalon ONE® Platform to rapidly deliver actionable analytical insights, empowering superior care delivery by health plans to their millions of members, and create positive, measurable economic performance impact.

“Over the past year, the challenges created by the COVID-19 pandemic combined with the rapid changes to how and where care is delivered have accelerated the need to rely upon a technology platform capable of addressing patient-specific gaps in care within the Medicare Advantage population,” said Kris Volrath, Vice President at Inovalon. “We are pleased to support and empower the continued strong performance of our clients, reflecting their adoption of industry-leading technologies and data-driven insights to achieve meaningful impact during an unprecedented year.”

About the CMS Star Ratings Program

The national Star Ratings performance program, instituted by CMS, measures and reports on a wide range of clinical and quality outcomes pertaining to members and health plans across the United States. The quality measures addressed are utilized by federal and state programs to determine quality scoring and associated incentives and penalties for such programs as CMS’ Medicare Advantage Five-Star Quality Rating System, the U.S. Department of Health and Human Services’ (HHS) Quality Ratings System (QRS) for Affordable Care Act (ACA) plans, and state-based Managed Medicaid measurement programs. Inovalon’s solutions support these programs, as

Read More